Published in Front Immunol on February 25, 2015
Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Oncotarget (2015) 0.84
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma. Front Immunol (2017) 0.75
Editorial: Recent Advances in HBV and HCV Immunology. Front Immunol (2015) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Hepatitis B virus immunopathogenesis. Annu Rev Immunol (1995) 8.62
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol (2004) 3.51
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology (2007) 3.34
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res (2005) 2.78
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol (2005) 2.58
Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med (2008) 2.52
Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol (2005) 2.24
How do regulatory T cells work? Scand J Immunol (2009) 2.02
PD-1 as a potential target in cancer therapy. Cancer Med (2013) 1.98
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. Neuro Oncol (2006) 1.92
The regulatory T cell family: distinct subsets and their interrelations. J Immunol (2003) 1.92
Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A (2009) 1.76
TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 1.49
Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol (2008) 1.43
Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology (2007) 1.35
Generation and function of induced regulatory T cells. Front Immunol (2013) 1.12
Notch1 signaling and regulatory T cell function. J Immunol (2008) 1.09
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Digestion (2012) 0.97
Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat (2010) 0.94
Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. J Gastroenterol Hepatol (2014) 0.91
Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection. Clin Transl Gastroenterol (2012) 0.90
Chronic HBV infection outside treatment guidelines: is treatment needed? Antivir Ther (2012) 0.89
Immunological mechanisms of hepatitis B virus persistence in newborns. Indian J Med Res (2013) 0.84
Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling. World J Gastroenterol (2012) 0.84
Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection. Hum Immunol (2012) 0.81
'Hardcore' OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer. Oncoimmunology (2014) 0.77